Nightingale Health’s Acquisition of Yolife GmbH on the deal.
Nightingale Health Plc’sworld-leading blood testing platform is complemented with Yolife GmbH’s digital health capabilities in an acquisition where Nightingale acquires all shares of Yolife.
The acquisition of Yolife GmbH is expected to substantially support the development of Nightingale’s digital health capabilities. Nightingale aims at globally launching a mobile health application which will integrate its leading biotechnology with digital health capabilities. The founders of Yolife GmbH will stay with the company in order to assist Nightingale with reaching this aim.
Yolife GmbH was founded in 2019 by Tassilo Weber und Roope Kärki. The company offers a mobile application helping its users to live longer in good health through science-based lifestyle changes. The Yolife digital health solution learns from the user’s behavior and provides the user with a holistic wellbeing strategy made of challenges that motivate and help the user to achieve personal health goals.
Nightingale Health Plc with its seat in Helsinki (Finland) and listed with the Nasdaq First North Growth Market Finland is a leading biotechnology company. Nightingale, amongst others, provides a biotechnology platform which allows for a holistic health analysis from a single blood sample.
The honert + partner team included Florian Leßniak (Picture), Jan-Christian Heins and Dr. Thomas Grädler.
Law Firms: Honert + Partner;